Evidence map›Paper›PMID 25131595›Full record

ReviewEssays in biochemistry2014

Prion disease and the 'protein-only hypothesis'.

Jiyan Ma, Fei Wang

Open access · greenAbstract readReview
In one paragraph

Review in Essays in biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jiyan MaCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503, U.S.A.
Fei WangCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503, U.S.A.
Van Andel Institute · US

Funding

To investigate the contributions of lipid membranes to prion diseaseR01NS060729 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MA, JIYAN, SUREWICZ, WITOLD K · 2008 to 2017
$4.5M
Molecular Mechanism of Prion StrainR01NS071035 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MA, JIYAN · 2011 to 2015
$1.8M
NINDS NIH HHS R01 NS060729NINDS NIH HHS R01 NS071035
6 · The paper itself

Abstract

Prion disease is the only naturally occurring infectious protein misfolding disorder. The chemical nature of the infectious agent has been debated for more than half a century. Early studies on scrapie suggested that the unusual infectious agent might propagate in the absence of nucleic acid. The 'protein-only hypothesis' provides a theoretical model to explain how a protein self-replicates without nucleic acid, which predicts that a prion, the proteinaceous infectious agent, propagates by converting its normal counterpart into the likeness of itself. Decades of studies have provided overwhelming evidence to support this hypothesis. The latest advances in generating infectious prions with bacterially expressed recombinant prion protein in the presence of cofactors not only provide convincing evidence supporting the 'protein-only hypothesis', but also indicate a role of cofactors in forming prion infectivity and encoding prion strains. In the present chapter, we review the literature regarding the chemical nature of the infectious agent, describe recent achievements in proving the 'protein-only hypothesis', and discuss the remaining questions in this research area.

Indexed as

AnimalsHumansPrion DiseasesPrionsProtein FoldingPrions

Identifiers

PMID25131595
PMCPMC6760854
OpenAlexW2150826780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.